Another miRNA microarray analysis revealed that HDAC1 inhibition via shRNA led to miR-182 overexpression, which suppresses TGF-β/Smad pathway to alleviate coronary heart disease (Zhou et al., 2022). The gene discussed is HDAC1; the disease is coronary artery disorder.